By Tokio X'press Vaccine, flu, medical service, Pharmaceutical
COVID-19: Chugai expands indications for antibody cocktail therapy: Lonapreve
Shionogi:Production of corona oral medicine: Approval application by the end of the year
Kyoto University: Reproduce intractable disease ALS with iPS cells: Therapeutic drug “Bosutinib”
COVID-19: Shionogi, final clinical trial with corona drug: S-217622
Muslims receive food donations at Tokyo mosque